Clinical Utility of SPECT Neuroimaging in the Diagnosis and Treatment of Traumatic Brain Injury: A Systematic Review

This systematic review evaluated the clinical utility of single photon emission computed tomography (SPECT) in traumatic brain injury (TBI). After defining a PICO Statement (Population, Intervention, Comparison and Outcome Statement), PRISMA (Preferred Reporting Items for Systematic Reviews and Meta...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 9; no. 3; p. e91088
Main Authors Raji, Cyrus A., Tarzwell, Robert, Pavel, Dan, Schneider, Howard, Uszler, Michael, Thornton, John, van Lierop, Muriel, Cohen, Phil, Amen, Daniel G., Henderson, Theodore
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 19.03.2014
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This systematic review evaluated the clinical utility of single photon emission computed tomography (SPECT) in traumatic brain injury (TBI). After defining a PICO Statement (Population, Intervention, Comparison and Outcome Statement), PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) criteria were applied to identify 1600 articles. After screening, 374 articles were eligible for review. Inclusion for review was focus on SPECT in the setting of mild, moderate, or severe TBI with cerebral lobar specificity of SPECT findings. Other inclusion criteria were comparison modalities in the same subjects and articles in English. Foreign language articles, SPECT studies that did not include comparison modalities, and case reports were not included for review. We identified 19 longitudinal and 52 cross-sectional studies meeting inclusion criteria. Three longitudinal studies examined diagnostic predictive value. The first showed positive predictive value increases from initial SPECT scan shortly after trauma to one year follow up scans, from 59% to 95%. Subsequent work replicated these results in a larger cohort. Longitudinal and cross sectional studies demonstrated SPECT lesion localization not detected by CT or MRI. The most commonly abnormal regions revealed by SPECT in cross-sectional studies were frontal (94%) and temporal (77%) lobes. SPECT was found to outperform both CT and MRI in both acute and chronic imaging of TBI, particularly mild TBI. It was also found to have a near 100% negative predictive value. This review demonstrates Level IIA evidence (at least one non-randomized controlled trial) for the value of SPECT in TBI. Given its advantages over CT and MRI in the detection of mild TBI in numerous studies of adequate quality, and given its excellent negative predictive value, it may be an important second test in settings where CT or MRI are negative after a closed head injury with post-injury neurological or psychiatric symptoms.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Article-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ObjectType-Undefined-4
Competing Interests: John Thornton is affiliated to Rossiter-Thornton Associates and Howard Schneider to Sheppard Associates. Muriel van Lierop belongs to a private practice corporation which has no research funding. Dr. Uszler is Medical Director of Drspectscan.com and co-owner of Neuro-Luminance Corp, both of which are clinical service corporations with no research funding. Dr. Pavel is Director of PathFinder Brain SPECT which is a clinical service corporation providing SPECT functional neuroimaging and has no research funding. Dr. Amen is owner of Amen Clinics, which provides SPECT functional neuroimaging and other diagnostic and clinical services. Dr. Henderson is President and owner of Dr. Theodore Henderson, Inc. and The Synaptic Space and co-owner of Neuro-Luminance Corp, which are clinical service or consulting corporations with no research funding. Drs. Raji, Tarzwell, and Cohen have no conflicts of interest or financial disclosures. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Conceived and designed the experiments: CR RT DP HS MU JT MvL PC DA TH. Performed the experiments: CR RT TH. Analyzed the data: CR TH. Wrote the paper: CR RT DP HS MU JT MvL PC DA TH.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0091088